Education
About Us
Working with TipRanks
Follow Us
NATCO Pharma Limited (IN:NATCOPHARM)
:NATCOPHARM
Total Valuation
NATCO Pharma Limited has a market cap or net worth of ₹157.86B. The enterprise value is ₹103.19B.
Market Cap₹157.86B
Enterprise Value₹103.19B
Share Statistics
NATCO Pharma Limited has 179,109,860 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding179,109,860
Owned by Insiders―
Owned by Institutions0.06%
Financial Efficiency
NATCO Pharma Limited’s return on equity (ROE) is 0.25 and return on invested capital (ROIC) is 20.24%.
Return on Equity (ROE)0.25
Return on Assets (ROA)0.22
Return on Invested Capital (ROIC)20.24%
Return on Capital Employed (ROCE)0.26
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.51
Inventory Turnover1.98
Valuation Ratios
The current PE Ratio of NATCO Pharma Limited is 0.00. NATCO Pharma Limited’s PEG ratio is 0.04.
PE Ratio0.00
PS Ratio0.00
PB Ratio2.11
Price to Fair Value0.00
Price to FCF15.98
Price to Operating Cash Flow12.11
PEG Ratio0.04
Income Statement
In the last 12 months, NATCO Pharma Limited had revenue of 44.30B and earned 18.85B in profits. Earnings per share was 105.26.
Revenue44.30B
Gross Profit29.10B
Operating Income19.61B
Pretax Income22.91B
Net Income18.85B
EBITDA25.50B
Earnings Per Share (EPS)105.26
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
NATCO Pharma Limited pays an annual dividend of ₹1.5, resulting in a dividend yield of 0.68%
Dividend Per Share₹1.5
Dividend Yield0.68%
Payout Ratio5.70%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.07
52-Week Price Change-26.45%
50-Day Moving Average855.41
200-Day Moving Average1.15K
Relative Strength Index (RSI)49.92
Average Volume (3m)64.62K
Important Dates
NATCO Pharma Limited upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.
Last Earnings DateMay 28, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend DateFeb 18, 2025
Financial Position
NATCO Pharma Limited as a current ratio of 5.59, with Debt / Equity ratio of 3.42%
Current Ratio5.59
Quick Ratio4.77
Debt to Market Cap0.00
Net Debt to EBITDA-0.74
Interest Coverage Ratio82.04
Taxes
In the past 12 months, NATCO Pharma Limited has paid 4.08B in taxes.
Income Tax4.08B
Effective Tax Rate0.18
Enterprise Valuation
NATCO Pharma Limited EV to EBITDA ratio is -0.74, with an EV/FCF ratio of -1.33.
EV to Sales-0.43
EV to EBITDA-0.74
EV to Free Cash Flow-1.33
EV to Operating Cash Flow-1.04
Balance Sheet
NATCO Pharma Limited has ₹24.63B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹24.63B billion.
Cash & Marketable Securities₹24.63B
Total Debt₹0.00
Net Cash-₹24.63B
Net Cash Per Share-₹137.54
Tangible Book Value Per Share₹0.00
Margins
Gross margin is 76.83%, with operating margin of 44.27%, and net profit margin of 42.56%.
Gross Margin76.83%
Operating Margin44.27%
Pretax Margin51.73%
Net Profit Margin42.56%
EBITDA Margin57.58%
EBIT Margin52.27%
Analyst Forecast
The average price target for NATCO Pharma Limited is ₹1,006.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target₹1,006.50
Price Target Upside16.70% Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―